Related Experiment Video
Updated: Mar 8, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
Fuchs' Endothelial Corneal Dystrophy and Cardiometabolic Comorbidities
Andrew Mihalache1, Ryan S Huang1, Marko M Popovic2
1Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Insights
Individuals with Fuchs' endothelial corneal dystrophy showed a greater prevalence of cardiometabolic diseases compared to control groups. This finding highlights a potential link between corneal health and systemic metabolic conditions.
Area of Science:
- Ophthalmology
- Cardiology
- Endocrinology
Background:
- Fuchs' endothelial corneal dystrophy is a progressive eye condition affecting the cornea.
- Cardiometabolic diseases encompass conditions like diabetes, obesity, and heart disease.
- The relationship between ocular surface diseases and systemic health is an area of growing research interest.
Purpose of the Study:
- To investigate the association between Fuchs' endothelial corneal dystrophy and cardiometabolic disease burden.
- To compare cardiometabolic disease prevalence in patients with Fuchs' dystrophy versus a matched control cohort.
Main Methods:
- Retrospective cohort study design.
- Utilized data from the National Institutes of Health All of Us Research Program.
- Included 548 individuals diagnosed with Fuchs' endothelial corneal dystrophy and 5,480 matched controls.
Main Results:
- Patients with Fuchs' endothelial corneal dystrophy presented with a significantly higher burden of cardiometabolic disease.
- The study identified a notable disparity in cardiometabolic risk factors between the case and control groups.
Conclusions:
- Fuchs' endothelial corneal dystrophy may be associated with an increased prevalence of cardiometabolic diseases.
- Further research is warranted to explore the underlying mechanisms and clinical implications of this association.
No abstract available in PubMed .
More Related Videos
06:35Author Spotlight: Insights into Cardiometabolic Diseases with Subcutaneous Adipose Tissue Microvasculature Studies
Published on: April 5, 2024
12:36A Human Corneal Organ Culture Model of Descemet's Stripping Only with Accelerated Healing Stimulated by Engineered Fibroblast Growth Factor 1
Published on: July 22, 2022
Related Concept Videos
Coronary Artery Disease I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Coronary Artery Disease II: Pathophysiology
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy I: Introduction and Classification